GlassScriptPhysician profile
William Anthony Messer
NPI 1700814985
$4,295.74
in general payments reported to CMS, 2019-2025
45 companies · $545 in 2025
The $545 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $939 · 2020: $615 · 2021: $697 · 2022: $501 · 2023: $448 · 2024: $551 · 2025: $545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,543.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $577.68 | 2019-2025 | Farxiga, Breztri |
| Novo Nordisk INC | $480.55 | 2019-2025 | Rybelsus, Ozempic, Tresiba |
| Amgen INC. | $440.24 | 2019-2025 | Repatha, Otezla, Evenity |
| Abbvie INC. | $413.62 | 2019-2025 | |
| Glaxosmithkline, LLC. | $278.96 | 2020-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbott Laboratories | $268.94 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2, Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $196.94 | 2019-2024 | Xifaxan |
| Amarin Pharma, INC. | $172.13 | 2019-2021 | |
| Pfizer INC. | $166.05 | 2019-2025 | |
| Astellas Pharma US INC | $132.97 | 2019-2023 | Veozah |
| Lilly USA, LLC | $122.48 | 2020-2025 | Zepbound |
| Inari Medical, INC. | $102.50 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Merck Sharp & Dohme LLC | $93.77 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $92.30 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $82.31 | 2019-2020 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Messer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.